EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Omics Biomarkers in Precision Oncology: From the Lens of the ASCPT Biomarkers and Translational Tools and Oncology Communities

Mai Mehanna iD, Hardik Mody, Joy C Hsu iD, Julia Quintanilha, Zachary L Taylor iD, Angela James, Binita Rajbanshi, Pooja Manchandani iD, Lakshmi Manasa Chekka iD

Clinical and Translational Science · 2026-08 · 19 (8)

DOI: 10.1111/cts.70712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 17.08.2026. Verfasst von Mai Mehanna und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy Department, Faculty of Pharmacy, Misr International University, Cairo, Egypt. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Genomics, Neoplasms, Precision Medicine. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Omics biomarkers comprise several molecular entities, including genomic, epigenomic, transcriptomic, proteomic, and metabolomic signatures. They play an essential role in oncology drug development and clinical settings by enabling personalized medicine. In precision oncology, validating biomarkers is a greater challenge than discovering them. The biomarkers discussed here span a wide evidentiary spectrum, from those endorsed in clinical guidelines to those that remain investigational.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorGenomicsNeoplasmsPrecision MedicineTranslational Research, BiomedicalHumansMedical OncologyMetabolomicsMultiomicsProteomics

Stichwörter der Autor:innen

biomarkersomicsoncologyprecision medicine

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Clinical Pharmacy Department, Faculty of Pharmacy, Misr International University, Cairo, Egypt.
  • Clinical Pharmacology, Genentech, South San Francisco, California, USA.
  • Clinical Development, Foundation Medicine, Inc., Boston, Massachusetts, USA.
  • Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID-Profile: Mai Mehanna, Joy C Hsu, Zachary L Taylor, Pooja Manchandani, Lakshmi Manasa Chekka

Zitieren

APA

Mehanna, M., Mody, H., Hsu, J. C., Quintanilha, J., Taylor, Z. L., James, A., Rajbanshi, B., Manchandani, P., & Chekka, L. M. (2026). Omics Biomarkers in Precision Oncology: From the Lens of the ASCPT Biomarkers and Translational Tools and Oncology Communities. Clinical and Translational Science, 19(8). https://doi.org/10.1111/cts.70712

Vancouver

Mehanna M, Mody H, Hsu JC, Quintanilha J, Taylor ZL, James A, et al. Omics Biomarkers in Precision Oncology: From the Lens of the ASCPT Biomarkers and Translational Tools and Oncology Communities. Clinical and Translational Science. 2026;19(8). doi:10.1111/cts.70712

BibTeX
@article{Mehanna2026,
  author = {Mehanna, Mai and Mody, Hardik and Hsu, Joy C and Quintanilha, Julia and Taylor, Zachary L and James, Angela and Rajbanshi, Binita and Manchandani, Pooja and Chekka, Lakshmi Manasa},
  title = {Omics Biomarkers in Precision Oncology: From the Lens of the ASCPT Biomarkers and Translational Tools and Oncology Communities},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {8},
  doi = {10.1111/cts.70712}
}
Kostenlos starten →